Amylyx Pharmaceuticals, Inc. ( AMLX ) Q1 2026 Earnings Call May 7, 2026 8:00 AM EDT Company Participants Lindsey Allen - Head of Investor Relations & Communications Justin Klee - Co-Founder, Co-CEO & Director Dan Monahan - Chief Commercial Officer Camille Bedrosian - Chief Medical Officer James Frates - Chief Financial Officer Joshua Cohen - Co-Founder, Co-CEO & Director Conference Call Participants Seamus Fernandez - Guggenheim Securities, LLC, Research Division Kevin Strang - Goldman Sachs Group, Inc., Research Division Michael DiFiore - Evercore ISI Institutional Equities, Research Division Marc Goodman - Leerink Partners LLC, Research Division Geoffrey Meacham - Citigroup Inc., Research Division Rami Katkhuda - LifeSci Capital, LLC, Research Division Samuel Lee - Mizuho Securities USA LLC, Research Division Christopher Chen - Robert W. Baird & Co. Incorporated, Research Division Ananda Ghosh - H.C. Wainwright & Co, LLC, Research Division Presentation Operator Good morning.…